Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017
Twitter Feed
-
@Eriktwits Head Innovation Solutions shared his thoughts on what it takes to form successful partnerships and how we should embrace each other’s differences. Watch a clip of his presentation at #HIMSSEurope19 https://t.co/UjnVv2V3AD
— UCB News (@ucb_news) 26.06.2019 -
Thank you #IEC2019 @IlaeWeb for a wonderful congress! Over the past days we’ve exchanged knowledge with epilepsy experts from around the world. We’ve really enjoyed sharing our passion and commitment to improving patient lives. We’re looking forward to #E
— UCB News (@ucb_news) 26.06.2019 -
Lyrics by The Beatles give Nejma comfort when times are tough with MG and remind her of her best buddy from when she was in hospital. Share the song that helps you when MG flares, using #mygroove, and it will be added to a global playlist. #mgstrong #mgc
— UCB News (@ucb_news) 25.06.2019
